- Conditions
- Coronary Artery Disease, Cerebrovascular Disease, Peripheral Vascular Disease
- Interventions
- Rifalazil
- Drug
- Lead sponsor
- ActivBiotics
- Industry
- Eligibility
- 50 Years to 85 Years
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 5
- States / cities
- Lansing, Michigan • Roslyn, New York • Stony Brook, New York + 2 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–3
of 3
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Peripheral Vascular Diseases, Intermittent Claudication
- Interventions
- Rifalazil
- Drug
- Lead sponsor
- ActivBiotics
- Industry
- Eligibility
- 40 Years to 80 Years
- Enrollment
- 274 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 23
- States / cities
- Scottsdale, Arizona • Palo Alto, California • San Diego, California + 20 more
- Conditions
- Chlamydia Trachomatis Infection
- Interventions
- Rifalazil 25 milligram, Azithromycin 1 gram
- Drug
- Lead sponsor
- ActivBiotics Pharma, LLC
- Industry
- Eligibility
- 19 Years and older · Female only
- Enrollment
- 82 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • San Diego, California • Indianapolis, Indiana + 2 more